Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.

Rodón L, Svensson RU, Wiater E, Chun MGH, Tsai WW, Eichner LJ, Shaw RJ, Montminy M.

Sci Adv. 2019 Jul 24;5(7):eaaw6455. doi: 10.1126/sciadv.aaw6455. eCollection 2019 Jul.

2.

Adaptive Transcriptional Responses by CRTC Coactivators in Cancer.

Tasoulas J, Rodon L, Kaye FJ, Montminy M, Amelio AL.

Trends Cancer. 2019 Feb;5(2):111-127. doi: 10.1016/j.trecan.2018.12.002. Epub 2019 Jan 29. Review.

PMID:
30755304
3.

USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination.

Iyengar PV, Jaynes P, Rodon L, Lama D, Law KP, Lim YP, Verma C, Seoane J, Eichhorn PJ.

Sci Rep. 2015 Oct 5;5:14733. doi: 10.1038/srep14733.

4.

Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.

Rodón L, Gonzàlez-Juncà A, Inda Mdel M, Sala-Hojman A, Martínez-Sáez E, Seoane J.

Cancer Discov. 2014 Oct;4(10):1230-41. doi: 10.1158/2159-8290.CD-14-0275. Epub 2014 Aug 1.

5.

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.

Eichhorn PJ, Rodón L, Gonzàlez-Juncà A, Dirac A, Gili M, Martínez-Sáez E, Aura C, Barba I, Peg V, Prat A, Cuartas I, Jimenez J, García-Dorado D, Sahuquillo J, Bernards R, Baselga J, Seoane J.

Nat Med. 2012 Feb 19;18(3):429-35. doi: 10.1038/nm.2619.

PMID:
22344298
6.

TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.

Anido J, Sáez-Borderías A, Gonzàlez-Juncà A, Rodón L, Folch G, Carmona MA, Prieto-Sánchez RM, Barba I, Martínez-Sáez E, Prudkin L, Cuartas I, Raventós C, Martínez-Ricarte F, Poca MA, García-Dorado D, Lahn MM, Yingling JM, Rodón J, Sahuquillo J, Baselga J, Seoane J.

Cancer Cell. 2010 Dec 14;18(6):655-68. doi: 10.1016/j.ccr.2010.10.023.

Supplemental Content

Support Center